(*3*)Three employees of a city-based pharmaceutical agency, whose cough syrup is alleged to have led to the loss of life of 18 kids in Uzbekistan final yr, have been arrested on fees of manufacturing and sale of adulterated medication, officers mentioned.
The arrests have been made after an FIR was lodged late Thursday evening in opposition to 5 officers of Marion Biotech, together with two of its administrators, over a criticism by a medicine inspector of the Central Drugs Standard Control Organization (CDSCO), they mentioned.
Police mentioned the administrators are at giant and a search is underway to apprehend them.
Central and Uttar Pradesh drug authorities had checked samples of Marion Biotech merchandise and located 22 of them to be “not of customary high quality” (adulterated and spurious), in accordance with the complainant drug inspector.
“Three folks related to Marion Biotech, which is situated in Sector 67, have been in the present day arrested by the native Phase 3 police station officers. These folks have been engaged in preparation and sale of faux medication which brought about critical hurt to public,” Additional Deputy Commissioner of Police (Central Noida) Rajiv Dixit mentioned.
“Besides the three suspects who’ve been arrested, there are two extra administrators of the corporate for whom searches are underway and they’re going to even be arrested quickly. With their act, these folks have been endangering human life and human well being,” Dixit mentioned.
The officer added {that a} complete authorized investigation within the case will likely be carried out.Phase 3 police station in-charge Vijay Kumar mentioned these arrested have been recognized as Tuhin Bhattacharya, head operation; Atul Rawat, manufacturing chemist; and Mool Singh, analytical chemist.
The absconding administrators of the agency who’ve been booked are Jaya Jain and Sachin Jain, Kumar mentioned.
The FIR was registered beneath Indian Penal Code sections 274 (adulteration of medication), 275 (sale of adulterated medication), 276 (sale of drug as a special drug or medical preparation) in addition to beneath part 17 (misbranded medication) and associated violations of the Drugs and Cosmetics Act, 1940.
Marion Biotech had come beneath the scanner in December final yr for its cough syrup Dok-1 that’s suspected to have led to the loss of life of 18 kids who consumed it in Uzbekistan after which the CDSCO launched a probe into the matter.
The manufacturing licence of the agency was suspended in January after inspections at its website by the central and the state drug authorities within the wake of the controversy.
On January 12, the World Health Organization (WHO) had issued a ‘medical product alert’, referring to 2 substandard (contaminated) merchandise, recognized in Uzbekistan and reported to it on December 22, 2022.
“The two merchandise are AMBRONOL syrup and DOK-1 Max syrup. The acknowledged producer of each merchandise is MARION BIOTECH PVT. LTD, (Uttar Pradesh, India). To date, the acknowledged producer has not offered ensures to WHO on the protection and high quality of these merchandise,” the WHO had mentioned then.
“Laboratory evaluation of samples of each merchandise, undertaken by nationwide high quality management laboratories of the Ministry of Health of the Republic of Uzbekistan discovered each merchandise contained unacceptable quantities of diethylene glycol and/or ethylene glycol as contaminants,” it had famous.
